Globe Life Inc.

Valuation Analysis

About the Company

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was former

Globe Life Inc. Stock at a Glance

Globe Life Inc. (GL) is currently trading at $166.76 with a market capitalization of $12.9B. The trailing P/E ratio stands at 11.53x, with a forward P/E of 10.02x. The 52-week range spans from $116.73 to $168.27; the current price is 0.9% below the yearly high. Year-over-year revenue growth stands at +5.4%. The net profit margin stands at 19.38%.

💰 Dividend

Globe Life Inc. pays an annual dividend of $1.32 per share, representing a yield of 0.79%. The payout ratio stands at 7.89%.

📊 Analyst Rating

11 analysts rate Globe Life Inc. (GL) on consensus: Buy. The average price target is $175.91, implying +5.49% from the current price. Analyst price targets range from $147.00 to $208.00.

Globe Life Inc.: The Investment Case in Detail

Globe Life Inc. (GL) operates in the Financial Services — specifically Insurance - Life — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Free cash flow is positive and net margins stand at 19.38%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Valuation in Context

The PEG ratio at 1.3 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 9.63x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

What to Watch Next

• The forward P/E of 10.02x is meaningfully below the trailing 11.53x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 97.1% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Globe Life Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.